Free Trial

Cadrenal Therapeutics (CVKD) Institutional Ownership

Cadrenal Therapeutics logo
$5.11 -0.17 (-3.13%)
As of 12:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Cadrenal Therapeutics (NASDAQ:CVKD)

Current
Institutional Ownership
Percentage
7.92%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$665.03K
Number of
Institutional Sellers
(last 12 months)
0
Get CVKD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cadrenal Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CVKD Institutional Buying and Selling by Quarter

Cadrenal Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2026 DRW Securities LLC25,152$171K0.0%N/A1.075%
2/9/2026Geode Capital Management LLC14,528$98K0.0%+14.3%0.621%
1/1/2026 JPMorgan Chase & Co.7,500$103K0.0%N/A0.321%
11/17/2025Citadel Advisors LLC19,864$274K0.0%N/A0.957%
11/7/2025 JPMorgan Chase & Co.7,500$103K0.0%N/A0.366%
2/12/2025Geode Capital Management LLC10,554$153K0.0%N/A0.593%
8/9/2024Renaissance Technologies LLC59,491$28K0.0%-59.8%0.372%
2/13/2024Armistice Capital LLC414,285$307K0.0%-57.8%3.182%
11/15/2023Armistice Capital LLC982,285$668K0.0%N/A7.544%


CVKD Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Cadrenal Therapeutics shares: Citadel Advisors LLC ($274K), DRW Securities LLC ($171K), JPMorgan Chase & Co. ($103K), and Geode Capital Management LLC ($98K), Renaissance Technologies LLC ($28K).Learn more on Cadrenal Therapeutics' institutional investors.

7.92% of Cadrenal Therapeutics' stock is owned by institutional investors. Learn more on CVKD's institutional investor holdings.

The following institutional investors have purchased Cadrenal Therapeutics' stock in the last 24 months: DRW Securities LLC ($25.15K), Citadel Advisors LLC ($19.86K), JPMorgan Chase & Co. ($15K), and Geode Capital Management LLC ($12.37K).

Institutional investors have bought a total of 61,834 shares in the last 24 months. This purchase volume represents approximately $665.03K in transactions.



This page (NASDAQ:CVKD) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners